Physician profile
Robin Mcnair
NPI 1043211279
$555.55
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.82 · 2020: $48.64 · 2022: $86.17 · 2023: $20.41 · 2024: $172 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $256.90 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $77.44 | 2019-2020 | |
| Glaxosmithkline, LLC. | $62.29 | 2022-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $49.63 | 2022-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $25.29 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $21.12 | 2024 | |
| Biomerieux INC | $20.41 | 2023 | |
| Tris Pharma INC | $15.07 | 2019 | |
| Sanofi Pasteur INC. | $14.59 | 2019 | |
| Medline Industries LP | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Mcnair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.